FMP

FMP

Enter

PLXP - PLx Pharma Inc.

photo-url-https://images.financialmodelingprep.com/symbol/PLXP.png

PLx Pharma Inc.

PLXP

NASDAQ

Inactive Equity

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores, and e-commerce channels. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey.

0.087 USD

0 (0%)

Historical Prices

From:

To:

We are unable to load the chart at this time.

fmp-logo

About

ceo

Ms. Natasha Giordano

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

exchange

NASDAQ

Description

PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other aspirin and non-steroidal anti-inflammatory drug products; and Vazalore 81 mg liquid-filled aspirin capsules. Its product pipeline also includes PL1200 Ibuprofen 200 mg; and PL1100 Ibuprofen 400 mg, which are in Phase I clinical stage for pain, inflammation, and fever. The company sells its products through drugstores, mass merchandisers, grocery stores,...

CIK

0001497504

ISIN

US72942A1079

CUSIP

72942A107

Address

9 Fishers Lane

Phone

973 409 6541

Country

US

Employee

16

IPO Date

Mar 13, 2014

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

PLXP Financial Summary

CIK

0001497504

Exchange

NASDAQ

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

72942A107

ISIN

US72942A1079

Country

US

Price

0.09

Beta

3.92

Volume Avg.

4.86M

Market Cap

2.53M

Shares

-

52-Week

0.009-3.41

DCF

3.62

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

-0.22

P/B

-

Website

https://plxpharma.com

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

Latest PLXP News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep